https://www.selleckchem.com/pr....oducts/lanraplenib.h
01), cardiac risk (β = -.74, p less then .01), and metabolic risk (β = -.88, p less then .01). Sedentary behavior significantly moderated the effect of MVPA on anthropometric (β-interaction = .49, p less then .01), cardiac (β-interaction = .45, p less then .01), and metabolic risk (β-interaction = .77, p less then .01), such that more MVPA was associated with better health outcomes under conditions of lower sedentary behavior. The model explained 13%, 22%, and 45% variance in anthropometric, cardiac, and metabolic risk factors, resp
Like
Comment
Share
